XNK Therapeutics appoints Dr. Peter Hovstadius as CMO

/PRNewswire/ -- XNK Therapeutics AB ("XNK") today announced the appointment of Dr. Peter Hovstadius as Chief Medical Officer (CMO), effective immediately. Dr....

Related Keywords

Sweden ,Stockholm ,Uppsala ,Uppsala Lan ,Huddinge ,Johan Liwing ,Johan Aschan ,Peter Hovstadius ,Uppsala University ,Clinical Development Of The Novel Cyanoguanidine ,Novartis ,Chief Medical Officer ,Senior Medical ,Clinical Development ,Novel Cyanoguanidine ,Cancer Treatment ,Medical Director ,Chief Scientific Officer ,Chief Innovation Officer ,Senior Medical Advisor ,Xnk Therapeutics Ab ,